Potential impacts of the EU IVD-Regulation on clinical flow cytometry.
Maurizio Suppo provides an overview of the new EU IVD-Regulation and elaborates on how EU authorities will regulate the vast majority of the laboratory-developed tests currently performed across Europe on a daily basis.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
Other News
Featured Supplier
ScheBo® • Biotech AG is an innovative biotech company that is active in the field of development, production and marketing of diagnostics.
The manufacturing of our leading products is matched exactly to satisfy of our customers.
ScheBo® • Biotech AG was founded by the biochemists and molecular biologists Ursula Scheefers-Borchel, Ph.D.,...
Upcoming Events
COVID-19 - The Infection Challenging the World
Online
11-14 May 2021
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
